Physician profile
Desh B Sharma
NPI 1457549032
$4,608.78
in general payments reported to CMS, 2019-2025
23 companies · $807 in 2025
The $807 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $278 · 2021: $769 · 2022: $1,053 · 2023: $604 · 2024: $465 · 2025: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,876.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,557.39 | 2019-2025 | Skyrizi, Rinvoq |
| Janssen Biotech, INC. | $646.81 | 2019-2025 | Tremfya, Stelara |
| Celgene Corporation | $391.94 | 2021-2024 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $233.92 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $196.27 | 2019-2023 | Imfinzi |
| Redhill Biopharma INC. | $154.80 | 2020-2022 | |
| Lilly USA, LLC | $144.82 | 2025 | Omvoh |
| Madrigal Pharmaceuticals | $139.24 | 2025 | Rezdiffra |
| Ipsen Biopharmaceuticals, INC | $124.99 | 2025 | Bylvay |
| Medtronic USA, INC. | $124.82 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $123.29 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $122.07 | 2021 | |
| Novo Nordisk INC | $115.33 | 2019 | |
| Braintree Laboratories, INC. | $110.81 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $110.17 | 2022-2023 | Rebyota |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $99.43 | 2019-2022 | |
| Qol Medical, LLC | $55.51 | 2021-2022 | |
| Boston Scientific Corporation | $54.44 | 2023 | |
| Cook Medical LLC | $42.86 | 2025 | Hemospray |
| Alnylam Pharmaceuticals INC. | $20.45 | 2022 | |
| Exact Sciences Corporation | $15.18 | 2023 | |
| Pfizer INC. | $13.26 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $10.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Desh Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.